The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Fourteau Patrick since 2006.
The trader's CIK number is 1235637.
At the time of the last reporting, Fourteau Patrick was the Chief Executive Offi of Insys Therapeutics, Inc.. (stock ticker symbol INSY).
Also see all insider trading activities at Insys Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | SCRX | 0 | $0 | 276,508 | $5,972,592 | 252,500 | $0 |
| 2007 | SCRX | 0 | $0 | 248,750 | $6,089,957 | 152,500 | $0 |
| 2006 | SCRX | 0 | $0 | 204,924 | $4,556,769 | 105,000 | $264,075 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | INSY | 0 | $0 | 0 | $0 | 20,000 | $52,500 |
| 2016 | INSY | 0 | $0 | 15,000 | $276,900 | 0 | $0 |
| 2015 | INSY | 0 | $0 | 55,159 | $2,303,483 | 0 | $0 |
| 2014 | INSY | 7,500 | $170,437 | 25,000 | $977,675 | 0 | $0 |
| 2013 | INSY | 65,000 | $663,980 | 0 | $0 | 0 | $0 |
1. First Horizon Pharmaceutical Corp (SCRX)
2. Insys Therapeutics, Inc. (INSY)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-08-15 | SCRX | Option Ex | 100,000 | .00 | 0 |
| 2008-08-15 | SCRX | Sale | 100,000 | 21.37 | 2,137,300 |
| 2008-05-15 | SCRX | Sale | 100,000 | 21.08 | 2,107,600 |
| 2008-05-15 | SCRX | Option Ex | 100,000 | .00 | 0 |
| 2008-02-15 | SCRX | Option Ex | 52,500 | .00 | 0 |
| 2008-02-15 | SCRX | Sale | 52,500 | 22.45 | 1,178,362 |
| 2008-01-23 | SCRX | Sale | 16,508 | 22.44 | 370,373 |
| 2008-01-24 | SCRX | Sale | 7,500 | 23.86 | 178,957 |
| 2007-12-07 | SCRX | Sale | 28,750 | 22.75 | 654,062 |
| 2007-10-31 | SCRX | Sale | 50,000 | 25.25 | 1,262,500 |
| 2007-09-10 | SCRX | Option Ex | 100,000 | .00 | 0 |
| 2007-09-10 | SCRX | Sale | 100,000 | 24.90 | 2,490,000 |
| 2007-05-16 | SCRX | Option Ex | 52,500 | .00 | 0 |
| 2007-05-16 | SCRX | Sale | 52,500 | 24.11 | 1,265,565 |
| 2007-01-24 | SCRX | Sale | 17,500 | 23.88 | 417,830 |
| 2006-11-01 | SCRX | Sale | 50,000 | 21.70 | 1,085,100 |
| 2006-08-01 | SCRX | Sale | 10,000 | 20.01 | 200,100 |
| 2006-08-02 | SCRX | Sale | 39,924 | 20.14 | 804,069 |
| 2006-05-16 | FHRX | Option Ex | 105,000 | 2.52 | 264,075 |
| 2006-05-16 | FHRX | Sale | 105,000 | 23.50 | 2,467,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-08-04 | INSY | Option Ex | 10,000 | 1.62 | 16,200 |
| 2017-05-26 | INSY | Option Ex | 10,000 | 3.63 | 36,300 |
| 2016-08-11 | INSY | Sale | 15,000 | 18.46 | 276,900 |
| 2015-11-12 | INSY | Sale | 30,000 | 26.48 | 794,400 |
| 2015-05-26 | INSY | Sale | 4,784 | 60.00 | 287,040 |
| 2015-05-27 | INSY | Sale | 1,311 | 60.14 | 78,843 |
| 2015-05-19 | INSY | Sale | 2,969 | 60.00 | 178,140 |
| 2015-05-20 | INSY | Sale | 6,095 | 60.00 | 365,700 |
| 2015-03-11 | INSY | Sale | 10,000 | 59.94 | 599,360 |
| 2014-11-19 | INSY | Sale | 25,000 | 39.11 | 977,675 |
| 2014-05-15 | INSY | Buy | 7,500 | 22.73 | 170,437 |
| 2013-08-14 | INSY | Buy | 5,000 | 23.77 | 118,850 |
| 2013-05-14 | INSY | Buy | 5,000 | 10.90 | 54,500 |
| 2013-05-13 | INSY | Buy | 2,000 | 11.10 | 22,200 |
| 2013-05-09 | INSY | Buy | 2,800 | 10.75 | 30,100 |
| 2013-05-08 | INSY | Buy | 200 | 10.40 | 2,080 |
| 2013-05-07 | INSY | Buy | 50,000 | 8.72 | 436,250 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fourteau Patrick (Chief Executive Offi of Insys Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.